Explore dsm-firmenich, our businesses, and other highlights.
On May 9, 2023, two global leaders in science and innovation joined forces to create dsm-firmenich, a company that delivers new breakthroughs in nutrition, health, and beauty.
26 Jun 2024
dsm-firmenich today announces the successful launch of its inaugural €800 million bond with a ten-year maturity due in 2034, at a coupon of 3.625%. The bond will be issued by DSM B.V. and will be guaranteed by DSM-Firmenich AG pursuant to the recently established cross-guarantee structure.
14 Jun 2024
On May 14, 2024, the Enterprise Chamber of the Court of Appeal in Amsterdam, the Netherlands (the Enterprise Chamber), rendered its judgment in the statutory buy-out proceedings initiated by DSM-Firmenich AG (the Company or dsm-firmenich) to acquire any shares of DSM B.V. (DSM) not already acquired by the Company in its previously completed voluntary cash tender offers for all outstanding DSM ordinary shares (the Shares).
12 Jun 2024
dsm-firmenich, innovators in nutrition, health and beauty, today announced an agreement to sell its yeast extract business (‘Yeast Extracts’) to Lesaffre, a key global player in fermentation and micro-organisms
03 Jun 2024
dsm-firmenich, the leading innovator in nutrition, health and beauty, will hold its Capital Markets Day (CMD) today in Paris. At the event, the company will present its strategy to investors and analysts.
31 May 2024
dsm-firmenich implements a cross guarantee agreement to mitigate structural subordination and establish a pari-passu debt platform.
A handy overview of the key dates in our financial calendar.
We believe in doing business the right way. And our policies and procedures support this ambition at every turn.
Our leaders all have proven track records in strategic execution and value creation. Supported by governance that ensures we do business the right way.
